Aurora B is an important kinase involved in dynamic cellular events in mitosis. Aurora B activity is controlled by several post-translational modifications (PTMs). Among them, E3 ubiquitin ligase-mediated ubiquitination plays crucial roles in controlling the relocation and degradation of Aurora B. Aurora B, ubiquitinated by different E3 ligases, moves to the exact site for its mitotic function during metaphase-anaphase transition and is then degraded for cell cycle progression at the end of mitosis. However, how the stability of Aurora B is maintained until its degradation has been poorly understood. Recently, we have found that USP35 acts as a deubiquitinating enzyme (DUB) for Aurora B and affects its stability during cell division, thus being involved in the regulation of mitosis. In this review, we discuss the USP35-mediated deubiquitination of Aurora B and the regulation of mitotic progression by USP35. [BMB Reports: Perspective 2018; 51(6): 261-262] Successful mitotic progression is tightly controlled by accurate coordination of chromosomes, microtubules, and membranes. During mammalian cell division, each daughter cell receives one of the two copies of each chromosome. If some errors occur in this process, new daughter cells can exhibit genetic instability and aneuploidy, consequently causing tumorigenesis. The ubiquitin-proteasome system is involved in the regulation of the activity of a number of mitotic proteins. In particular, modulation of the level and dynamic behavior of the Aurora B kinase, an enzymatic component of the chromosomal passenger protein complex (CPC), by ubiquitination is essential for key mitotic events, which include the regulation of kinetochore-microtubule dynamics, activation of the spindle assembly checkpoint, and completion of cytokinesis (Carmena et al. (2012) functions of USP35 in cellular responses, particularly in the cell cycle, remain largely unclear.
In the current study, we report that the DUB USP35 regulates mitotic progression by blocking the APC CDH1 -mediated degradation of Aurora B and maintaining Aurora B stability (Diagram 1). siRNA-mediated depletion of USP35 triggered an increase in several mitotic defects, including chromosome misalignment, lagging chromosomes, multipolar spindles and chromatin bridges. In addition, USP35 deficiency induced cytokinesis failure and mitotic slippage, resulting in severe nuclear abnormalities. These phenotypes, observed in USP35-deficient cells, were rescued by the expression of WT USP35 but not by the expression of a catalytically inactive form of USP35, USP35 C450A , which indicated that the DUB activity of USP35 is required for the regulation of mitotic progression. Based on these results, we could surmise that there existed a specific substrate, affected by the DUB activity of USP35, acting as a regulator of mitosis. The Aurora B kinase is important for faithful mitotic progression, and mitotic errors found in cells lacking USP35 are similar to those caused by Aurora B inhibition. Indeed, USP35 could bind to and deubiquitinate Aurora B during mitosis. In addition, USP35 controlled Aurora B levels in a proteasome-dependent manner. Finally, almost all mitotic defects caused by USP35 knockdown were recovered by inducing expression of Aurora B, which suggested that USP35 could participate in mitosis via regulation of Aurora B levels. Interestingly, USP35 suppressed the CDH1-induced ubiquitination of Aurora B and restored the protein levels of Aurora B decreased by CDH1. Based on the results, we concluded that USP35 counteracts the APC CDH1 effect on Aurora B. Additional ubiquitination of Aurora B by a Cul3-based E3 ligase alters the localization of Aurora B during mitosis. Although USP35 did not modify this ubiquitination of Aurora B, it is unclear whether USP35 is associated with the regulation of Aurora B localization during mitosis. USP35 could regulate histone H3 phosphorylation at Ser10 by Aurora B, indicating that USP35 affects Aurora B downstream signaling. Histone H3 phosphorylation is important for chromosome condensation at prophase and during cell passage from metaphase to anaphase (Hans F et al (2001) Oncogene 20, 3021-3027) . Hence, we demonstrate that at least the decrease in the number of mitotic cells and the mitotic delay exhibited in USP35-depleted cells are caused by reduction in the Aurora B-promoted histone H3 phosphorylation. Finally, we determined that USP35 expression was regulated by the FoxM1 transcription factor during the cell cycle. However, we do not know the molecular mechanism of regulation of the activity or expression of USP35 during mitosis. Overall, we believe that USP35 is a novel DUB regulating Aurora B levels and function, and therefore, controlling the whole mitotic progression.
